June 2015 Archive UM Ventures News Partner News Tokai Pharmaceuticals Announces Initiation of Phase 3 ARMOR3-SV Trial of Galeterone in AR-V7 Positive Metastatic Castration-Resistant Prostate CancerWednesday, June 24, 2015 Custom Battery Manufacturer, FlexEl, to Open State-of-the-Art-Facility in College ParkThursday, June 18, 2015 National Cancer Institute Accepts Rexahn's RX-21101 for Its Nanotechnology Characterization Laboratory's Preclinical Characterization ProgramMonday, June 8, 2015